Sanofi earnings beat view, lifts outlook

(Reuters) - French drugmaker Sanofi's posted better than expected earnings and lifted its profit guidance for the year on strong growth at its biotech arm Genzyme and helped by an early start to the U.S. flu vaccines season. Stepping up an overhaul initiated by Chief Executive Olivier Brandicourt, Sanofi also said it would sell its European generic drugs business and buy back 3.5 billion euros (3 billion pounds) worth of shares after receiving 4.7 billion euros under an asset swap agreement with